CASI Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,131.70
10,669.90
5,131.10
27,092.90
43,489.90
85,117
Total Accounts Receivable
-
23.70
-
-
-
-
Other Current Assets
279.80
328.20
438.20
355.90
322.50
7,164.60
Total Current Assets
15,411.40
11,021.80
5,569.30
27,448.80
43,812.40
92,564.60
Net Property, Plant & Equipment
78.10
261.80
218.80
229.60
1,046.50
1,750.60
Other Assets
18.00
26.00
38.20
34.50
242.00
310
Total Assets
15,507.60
11,309.60
5,826.30
27,712.90
45,101.00
113,410
Accounts Payable
-
491.60
884.10
1,064.60
2,087.80
Other Current Liabilities
565.20
427.40
169.50
251.00
2,974.30
Total Current Liabilities
565.20
919.00
1,053.60
1,315.60
5,062.10
Long-Term Debt
-
1,390.00
1,465.00
1,491.30
1,498.80
Other Liabilities
-
9,422.70
9,395.20
4,122.30
-
Total Liabilities
565.20
11,731.80
11,913.80
6,929.10
6,560.90
Common Equity (Total)
14,942.40
422.20
6,087.40
20,783.80
38,540.10
Total Shareholders' Equity
14,942.40
422.20
6,087.40
20,783.80
38,540.10
Total Equity
14,942.40
422.20
6,087.40
20,783.80
38,540.10
Liabilities & Shareholders' Equity
15,507.60
11,309.60
5,826.30
27,712.90
45,101.00
About CASI Pharmaceuticals
View Profile
